Advertisement
Screener

BioTelemetry, Inc. Forms 3, 4 and 5: Stock Options, 2019

BioTelemetry, Inc. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows in 2019. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2019-12-31: Reporting owner Ferola Peter; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2019-12-31: Reporting owner Ferola Peter; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2019-09-04: Reporting owner Ferola Peter; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2019-09-04: Reporting owner Ferola Peter; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2019-12-31Ferola Peter
Officer (SVP & General Counsel)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−1,632
1,633 owned after
$24.65
exercise price
2020-01-06
2019-12-31Ferola Peter
Officer (SVP & General Counsel)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−3,433
0 owned after
$9.57
exercise price
2020-01-06
2019-09-04Ferola Peter
Officer (SVP & General Counsel)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−6,835
0 owned after
$8.68
exercise price
2019-09-06
2019-09-04Ferola Peter
Officer (SVP & General Counsel)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−17,751
0 owned after
$10.36
exercise price
2019-09-06
2019-09-04Ferola Peter
Officer (SVP & General Counsel)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,293
3,433 owned after
$9.57
exercise price
2019-09-06
2019-09-04Ferola Peter
Officer (SVP & General Counsel)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−3,264
3,265 owned after
$24.65
exercise price
2019-09-06
2019-09-04Ferola Peter
Officer (SVP & General Counsel)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−1,853
5,561 owned after
$33.35
exercise price
2019-09-06
2019-05-03GORMAN KIRK E
Director
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−5,518
0 owned after
$17.67
exercise price
2019-05-07
2019-04-30GORMAN KIRK E
Director
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−5,518
5,518 owned after
$17.67
exercise price
2019-05-02
2019-02-14Wisniewski Daniel
Officer (SVP, Technical Operations)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+3,698
3,698 owned after
$76.01
exercise price
2019-02-19
2019-02-14Broadway Fred
Officer (President BioTel Heart)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+4,731
4,731 owned after
$76.01
exercise price
2019-02-19
2019-02-14Ferola Peter
Officer (SVP & General Counsel)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+3,665
3,665 owned after
$76.01
exercise price
2019-02-19
2019-02-14Getz Heather C
Officer (Executive VP & CFO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+9,395
9,395 owned after
$76.01
exercise price
2019-02-19
2019-02-14Capper Joseph H
Director, Officer (President & CEO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+26,062
26,062 owned after
$76.01
exercise price
2019-02-19
2019-02-01Getz Heather C
Officer (Executive VP & CFO)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,490
0 owned after
$2.80
exercise price
2019-02-01
2019-01-31Getz Heather C
Officer (Executive VP & CFO)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−100
10,490 owned after
$2.80
exercise price
2019-02-01
2019-01-29Getz Heather C
Officer (Executive VP & CFO)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−200
10,590 owned after
$70.002019-01-29
2019-01-28Getz Heather C
Officer (Executive VP & CFO)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−28,194
10,790 owned after
$2.80
exercise price
2019-01-29
2019-01-25Getz Heather C
Officer (Executive VP & CFO)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−38,524
0 owned after
$2.54
exercise price
2019-01-29
2019-01-25Getz Heather C
Officer (Executive VP & CFO)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−26,465
38,984 owned after
$2.80
exercise price
2019-01-29
2019-01-17Getz Heather C
Officer (Executive VP & CFO)
4Stock Options (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−8,236
39,272 owned after
$2.54
exercise price
2019-01-22